Can neuroscience be integrated into the DSM-V?

Nature Reviews Neuroscience

Volumn 8, Issue 9, 2007, Pages 725-732

  Hyman, Steven E ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; BRAIN FUNCTION; CONTENT VALIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; GILLES DE LA TOURETTE SYNDROME; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR DEPRESSION; NEUROSCIENCE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MENTAL DISORDERS; NEUROSCIENCES;

EID: 34548011214     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn2218     Document Type: Review

References (63)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (American Psychiatric Association, Washington D.C., 2000)
2. The ICD-10 Classification of Mental and Behavioural Disorders (World Health Organization, Geneva, 1992).
3. Mayberg, H. S. et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651-660 (2005).
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third edition (American Psychiatric Association, Washington D. C., 1980).
5. Robins, E. & Guze, S. B. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am. J. Psychiatry 126, 983-987 (1970).
6. Pope, H. G. Jr & Lipinski, J. F. Jr. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch. Gen. Psychiatry 35, 811-828 (1978).
7. Kendel, R. E. Clinical validity. Psychol. Med. 19, 45-55 (1989).
8. Kendler, K. S. & Gardner, C. O. Jr. Boundaries of major depression: an evaluation of DSM-IV criteria. Am. J. Psychiatry 155, 172-177 (1998).
9. Meehl, P. E. Schizotaxia revisited. Arch. Gen. Psychiatry 46, 935-944 (1989).
10. Fanous, A., Gardner, C., Walsh, D. & Kendler, K. S. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Arch. Gen. Psychiatry 58, 669-673 (2001).
11. Tsuang, M. T., Stone, W. S., Tarbox, S. I. & Faraone, S. V. in Advancing DSM: Dilemmas in Psychiatric Diagnosis (eds Phillips, K. A., First, M. B. & Pincus, H. A.) 105-128 (American Psychiatric Association, Washington D. C., 2003).
12. Hoekstra, R. A., Bartels, M., Verweij, C. J. & Boomsma, D. I. Heritability of autistic traits in the general population. Arch. Pediatr. Adolesc. Med. 161, 372-377 (2007).
13. Widiger, T. A. & Costa, P. T. Jr. Personality and personality disorders. J. Abnorm. Psychol. 103, 78-91 (1994).
14. Fairburn, C. G. & Bohn, K. Eating disorder NOS (EDNOS): an example of the troublesome "not otherwise specified" (NOS) category in DSM-IV. Behav. Res. Ther. 43, 691-701 (2005).
15. de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F. & Verheij, F. High rates of psychiatric co-morbidity in PDD-NOS. J. Autism Dev. Disord. 37, 877-886 (2007).
16. Goldstein, S. & Schwebach, A. J. The comorbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: results of a retrospective chart review. J. Autism Dev. Disord. 34, 329-339 (2004).
17. Reiersen, A. M., Constantino, J. N., Volk, H. E. & Todd, R. D. Autistic traits in a population-based ADHD twin sample. J. Child Psychol. Psychiatry 48, 464-472 (2007).
18. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617-627 (2005).
19. Weiss, R. D. et al. Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence. J. Affect. Disord. 79, 279-283 (2004).
20. Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C. & Eaves, L. J. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch. Gen. Psychiatry. 49, 716-722 (1992).
21. Skodol, A. E. et al. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol. Psychiatry 51, 936-950 (2002).
22. Craddock, N., O'Donovan, M. C. & Owen, M. J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42, 193-204 (2005).
23. Happe, F., Ronald, A. & Plomin, R. Time to give up on a single explanation for autism. Nature Neurosci. 9, 1218-1220 (2006).
24. Florez, J. C., Hirschhorn, J. & Altshuler, D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics Hum. Genet. 4, 257-291 (2003).
25. Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497-1500 (2004).
26. Binder, E. B. et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genet. 36, 1319-1325 (2004).
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (American Psychiatric Association, Washington D.C., 1994).
28. Kendler, K. S., Gatz, M., Gardner, C. O. & Pedersen, N. L. A Swedish national twin study of lifetime major depression. Am. J. Psychiatry 163, 109-114 (2006).
29. Freitag, C. M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 12, 2-22 (2007).
30. Kety, S. S., Rosenthal, D., Wender, P. H. & Schulsinger, F. Mental illness in the biological and adoptive families of adopted schizophrenics. Am. J. Psychiatry 128, 302-306 (1971).
31. Kendler, K. S., Gruenberg, A. M. & Strauss, J. S. An independent analysis of the Copenhagen sample of the Danish Adoption Study of schizophrenia. III. The relationship between paranoid psychosis (delusional disorder) and the schizophrenia spectrum disorders. Arch. Gen. Psychiatry 38, 985-987 (1981).
32. Sigvardsson, S., Bohman, M. & Cloninger, C. R. Replication of the Stockholm Adoption Study of alcoholism. Confirmatory cross-fostering analysis. Arch. Gen. Psychiatry 53, 681-687 (1996).
33. Merikangas, K. R. & Risch, N. Will the genomics revolution revolutionize psychiatry? Am. J. Psychiatry 160, 625-635 (2003).
34. Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet. 33 (Suppl.), 228-237 (2003).
35. Daiger, S. P., Bowne, S. J. & Sullivan, L. S. Perspective on genes and mutations causing retinitis pigmentosa. Arch. Ophthalmol. 125, 151-158 (2007).
36. McClellan, J. M., Susser, E. & King, M. C. Maternal famine, de novo mutations, and schizophrenia. JAMA 296, 582-584 (2006).
37. Kendler, K. S., Davis, C. G. & Kessler, R. C. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br. J. Psychiatry 170, 541-548 (1997).
38. Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892 (2002).
39. Levinson, D. F. The genetics of depression: a review. Biol. Psychiatry 60, 84-92 (2006).
40. Caspi, A. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389 (2003).
41. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA 98, 6917-6922 (2001).
42. Munafo, M. R., Bowes, L., Clark, T.G. & Flint, J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies Mol. Psychiatry 10, 765-770 (2005).
43. Craddock, N., Owen, M. J. & O'Donovan, M. C. The catechol-O- methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol. Psychiatry 11, 446-458 (2006).
44. Cardon, L. R. Genetics. Delivering new disease genes. Science 314, 1403-1405 (2006).
45. Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
46. Cannon, T. D. et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl Acad. Sci. USA 99, 3228-3233 (2002).
47. Thompson, P. M. et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl Acad. Sci. USA 98, 11650-11655 (2001).
48. Drevets, W. C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu. Rev. Med. 49, 341-361 (1998).
49. Mayberg, H. S. et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8, 1057-1061 (1997).
50. Mayberg, H. S. et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156, 675-682 (1999).
51. Faraone, S. V. et al. Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? Am. J. Psychiatry 152, 1286-1290 (1995).
52. Phillips, K. A., Price, L. H., Greenberg, B. D. & Rasmussen, S. A. in Advancing DSM: Dilemmas in Psychiatric Diagnosis (eds Phillips, K. A., First, M. B. & Pincus, H. A.) 57-84. (American Psychiatric Association, Washington D. C., 2003).
53. Cannon, T. D. et al. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am. J. Hum. Genet. 67, 369-382 (2000).
54. Brahmbhatt, S. B., Haut, K., Csernansky, J. G. & Barch, D. M. Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings. Schizophr. Res. 87, 191-204 (2006).
55. Niendam, T. A. et al. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am. J. Psychiatry 160, 2060-2062 (2003).
56. Tan, H. Y. et al. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. Am. J. Psychiatry 163, 1969-1977 (2006).
57. Barch, D. M. et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch. Gen. Psychiatry 58, 280-288 (2001).
58. Cannon, T. D. et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 62, 1205-1213 (2005).
59. Hyman, S. E. & Fenton, W. S. Medicine. What are the right targets for psychopharmacology? Science 299, 350-351 (2003).
60. Etkin, A. et al. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44, 1043-1055 (2004).
61. Shin, L. M. et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch. Gen. Psychiatry 62, 273-281 (2005).
62. Phelps, E. A. & LeDoux, J. E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48, 175-178 (2005).
63. Grob, G. N. Origins of DSM-I: a study in appearance and reality. Am. J. Psychiatry 148, 421-431 (1991).